Phase I/II trial of weekly bortezomib with lenalidomide and dexamethasone in first relapse or primary refractory myeloma.

Thumbnail
Fulltext:
171186.pdf
Size:
782.3Kb
Format:
PDF
Description:
Publisher’s version
Download
Publication year
2016
Author(s)
Broijl, A.
Kersten, M.J.
Alemayehu, W.G.
Levin, M.D.
Weerdt, O. de
Vellenga, E.
Meijer, E.
Wittebol, S.
Tanis, B.C.
Cornelisse, P.B.
Stevens-Kroef, M.J.
Bos, G.M.
Wijermans, P.W.
Lokhorst, H.
Sonneveld, P.
Source
Haematologica, 101, 4, (2016), pp. 149-52
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/171186   https://hdl.handle.net/2066/171186
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.